ZYVERSA THERAPEUTICS, INC. Dividends, Preferred Stock, Cash
ZYVERSA THERAPEUTICS, INC. (ZVSA) had Dividends, Preferred Stock, Cash of $6.70 million as of 2023-04-28, per its 10-Q filed 2023-11-14.
Discontinued › Shareholders' Equity
us-gaap:DividendsPreferredStockCash · last filed 2023-11-14
- 2023-04-28: Dividends, Preferred Stock, Cash $6.70M.
| Period end | Dividends, Preferred Stock, Cash |
|---|---|
| 2023-04-28 | $6.70M 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |